These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Impaired pulmonary vascular development in bronchopulmonary dysplasia. Baker CD; Abman SH Neonatology; 2015; 107(4):344-51. PubMed ID: 26044102 [TBL] [Abstract][Full Text] [Related]
11. Children with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Treated with Pulmonary Vasodilators-The Pediatric Cardiologist Point of View. Migdał A; Sądel-Wieczorek A; Ryciak E; Mirecka-Rola A; Brzezińska-Rajszys G; Żuk M Children (Basel); 2021 Apr; 8(5):. PubMed ID: 33922327 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature. Altit G; Dancea A; Renaud C; Perreault T; Lands LC; Sant'Anna G Paediatr Respir Rev; 2017 Jun; 23():16-26. PubMed ID: 27986502 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies. Young KC; Schmidt AF; Tan AW; Sbragia L; Elsaie A; Shivanna B Clin Perinatol; 2024 Mar; 51(1):21-43. PubMed ID: 38325942 [TBL] [Abstract][Full Text] [Related]
14. Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease. Fukasawa Y; Yamamoto H; Ito M; Saito A; Go K; Morimoto Y; Yasuda K; Sato Y; Hayakawa M; Kato T Front Pediatr; 2023; 11():1116434. PubMed ID: 36937960 [TBL] [Abstract][Full Text] [Related]
15. Long term cardiovascular consequences of chronic lung disease of prematurity. Poon CY; Edwards MO; Kotecha S Paediatr Respir Rev; 2013 Dec; 14(4):242-9. PubMed ID: 24209460 [TBL] [Abstract][Full Text] [Related]
16. Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension. Nawaytou H; Hills NK; Clyman RI Pediatr Res; 2023 Aug; 94(2):547-554. PubMed ID: 36804505 [TBL] [Abstract][Full Text] [Related]
17. Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study. Schneider S; Bailey M; Spears T; Esther CR; Laughon MM; Hornik CP; Jackson W BMC Pediatr; 2020 Dec; 20(1):559. PubMed ID: 33317479 [TBL] [Abstract][Full Text] [Related]
18. Successful Atrial Septal Defect Closure Subsequent to Medical Pulmonary Preconditioning in an Infant With Severe Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia. Sato M; Saiki H; Saito K; Sato A; Kuwata S; Nakano S; Koizumi J; Oyama K; Akasaka M Cureus; 2024 Mar; 16(3):e57290. PubMed ID: 38690499 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular magnetic resonance imaging derived septal curvature in neonates with bronchopulmonary dysplasia associated pulmonary hypertension. Critser PJ; Higano NS; Lang SM; Kingma PS; Fleck RJ; Hirsch R; Taylor MD; Woods JC J Cardiovasc Magn Reson; 2020 Jul; 22(1):50. PubMed ID: 32698897 [TBL] [Abstract][Full Text] [Related]
20. Placental Villous Vascularity Is Decreased in Premature Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. Yallapragada SG; Mestan KK; Palac H; Porta N; Gotteiner N; Hamvas A; Grobman W; Ernst LM Pediatr Dev Pathol; 2016; 19(2):101-7. PubMed ID: 26366786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]